We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
126
Boston Scientific
BSX
$68.4B
$238K 0.07%
17,600
+1,304
+8% +$17.1K
KDP icon
127
Keurig Dr Pepper
KDP
$43B
$235K 0.07%
4,311
-96,846
-96% -$4.88M
EXC icon
128
Exelon
EXC
$46.6B
$234K 0.07%
+9,779
New +$206K
DE icon
129
Deere & Co
DE
$162B
$232K 0.07%
2,550
-25
-1% -$2.19K
UBNK
130
DELISTED
UNITIED FINANCIAL BANCORP INC
UBNK
$230K 0.06%
12,510
-943
-7% -$17.2K
VOD icon
131
Vodafone
VOD
$37.2B
$228K 0.06%
6,208
-3,875
-38% -$149K
PAYX icon
132
Paychex
PAYX
$41.4B
$210K 0.06%
4,938
+4
+0.1% +$170
MA icon
133
Mastercard
MA
$510B
$206K 0.06%
2,765
+145
+6% +$11.3K
HPQ icon
134
HP
HPQ
$24.6B
$205K 0.06%
+13,969
New +$188K
PPG icon
135
PPG Industries
PPG
$24.9B
$204K 0.06%
+2,104
New +$200K
GLW icon
136
Corning
GLW
$116B
$203K 0.06%
+9,750
New +$183K
GSK icon
137
GSK
GSK
$104B
$201K 0.06%
+3,006
New +$203K
DEO icon
138
Diageo
DEO
$49.5B
$200K 0.06%
1,609
– –
HR icon
139
Healthcare Realty
HR
$7.46B
$193K 0.05%
8,479
– –
F icon
140
Ford
F
$59.3B
$173K 0.05%
11,063
-205
-2% -$3.17K
VER
141
DELISTED
VEREIT, Inc.
VER
$172K 0.05%
+2,455
New +$171K
SIRI icon
142
SiriusXM
SIRI
$10.4B
$144K 0.04%
+4,503
New +$159K
INFN
143
DELISTED
Infinera Corporation Common Stock
INFN
$136K 0.04%
15,000
+5,000
+50% +$43.8K
TLGT
144
DELISTED
Teligent, Inc
TLGT
$57K 0.02%
1,000
– –
CRIS icon
145
Curis
CRIS
$9.67M
$48K 0.01%
9
– –
ED icon
146
Consolidated Edison
ED
$40.4B
– –
-4,612
Closed -$255K
FFIV icon
147
F5
FFIV
$22.1B
– –
-38,209
Closed -$3.47M
JCI icon
148
Johnson Controls International
JCI
$87.2B
– –
-4,064
Closed -$218K
NKE icon
149
Nike
NKE
$62.7B
– –
-5,534
Closed -$218K
STAA icon
150
STAAR Surgical
STAA
$1.21B
– –
-10,265
Closed -$166K
3 4 5
6
7

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.